Evidence map›Paper›PMID 33101757›Full record

ArticleEngineering (Beijing, China)2021

Ultrasonic Characteristics and Severity Assessment of Lung Ultrasound in COVID-19 Pneumonia in Wuhan, China: A Retrospective, Observational Study.

Fengxue Zhu, Xiujuan Zhao, Tianbing Wang, Zhenzhou Wang, Fuzheng Guo, Haiyan Xue, Panpan Chang, Hansheng Liang, Wentao Ni, Yaxin Wang and 2 more

Abstract read
In one paragraph

Article in Engineering (Beijing, China), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Association of Lung Ultrasound Score with Mortality and Severity of COVID-19: A Meta-Analysis and Trial Sequential Analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fengxue ZhuTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Xiujuan ZhaoTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Tianbing WangTrauma Center, Key Laboratory of Trauma and Neural Regeneration (Peking University), Ministry of Education, Peking University People's Hospital, Beijing 100044, China.
Zhenzhou WangTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Fuzheng GuoTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Haiyan XueTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Panpan ChangTrauma Center, Key Laboratory of Trauma and Neural Regeneration (Peking University), Ministry of Education, Peking University People's Hospital, Beijing 100044, China.
Hansheng LiangAnesthesiology Department, Peking University People's Hospital, Beijing 100044, China.
Wentao NiRespiratory and Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Yaxin WangTrauma Center, Critical Care Medicine Department, Peking University People's Hospital, Beijing 100044, China.
Lei ChenRadiology Department, Peking University People's Hospital, Beijing 100044, China.
Baoguo JiangTrauma Center, Key Laboratory of Trauma and Neural Regeneration (Peking University), Ministry of Education, Peking University People's Hospital, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical application of lung ultrasound (LUS) in the assessment of coronavirus disease 2019 (COVID-19) pneumonia severity remains limited. Herein, we investigated the role of LUS imaging in COVID-19 pneumonia patients and the relationship between LUS findings and disease severity. This was a retrospective, observational study at Tongji Hospital in Wuhan, on 48 recruited patients with COVID-19 pneumonia, including 32 non-critically ill patients and 16 critically ill patients. LUS was performed and the respiratory rate oxygenation (ROX) index, disease severity, and confusion, blood urea nitrogen, respiratory rate, blood pressure, and age (CURB-65) score were recorded on days 0-7, 8-14, and 15-21 after symptom onset. Lung images were divided into 12 regions, and the LUS score (0-36 points) was calculated. Chest computed tomography (CT) scores (0-20 points) were also recorded on days 0-7. Correlations between the LUS score, ROX index, and CURB-65 scores were examined. LUS detected COVID-19 pneumonia in 38 patients. LUS signs included B lines (34/38, 89.5%), consolidations (6/38, 15.8%), and pleural effusions (2/38, 5.3%). Most cases showed more than one lesion (32/38, 84.2%) and involved both lungs (28/38, 73.7%). Compared with non-critically ill patients, the LUS scores of critically ill patients were higher (12 (10-18) vs 2 (0-5),

Indexed as

Coronavirus disease 2019Lung ultrasoundPneumonia

Identifiers

PMID33101757
PMCPMC7566678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.